EPAM
FHTX icon

Evelyn Partners Asset Management’s Foghorn Therapeutics FHTX Stock Holding History

Evelyn Partners Asset Management’s Portfolio FHTX Stock Details FHTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$33.9K Hold
7,100
– – 0.01% 193
2025
Q4 		$38.3K Hold
7,100
– – 0.01% 167
2025
Q3 		$34.7K Hold
7,100
– – 0.01% 170
2025
Q2 		$33.4K Hold
7,100
– – 0.01% 152
2025
Q1 		$25.9K Hold
7,100
– – 0.01% 169
2024
Q4 		$33.5K Buy
+7,100
New +$51.7K 0.01% 153

Other funds holding FHTX

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Evelyn Partners Asset Management's FHTX Position: Q1 2026 in Review

Evelyn Partners Asset Management held its Foghorn Therapeutics (FHTX) position steady in Q1 2026 at 7,100 shares worth $33.9K. The position accounts for 0.01% of the portfolio, ranked #193.

Evelyn Partners Asset Management first reported a position in FHTX in Q4 2024 and has held it in 6 quarters since. The position peaked at $38.3K in Q4 2025. 105 funds tracked by Wall St. Rank hold FHTX as of Q1 2026.

  • Evelyn Partners Asset Management held 7,100 shares of Foghorn Therapeutics worth $33.9K as of Q1 2026.
  • Evelyn Partners Asset Management left its Foghorn Therapeutics share count unchanged in Q1 2026.
  • Foghorn Therapeutics made up 0.01% of Evelyn Partners Asset Management's portfolio in Q1 2026, its #193 holding.
  • Evelyn Partners Asset Management first reported a position in Foghorn Therapeutics in Q4 2024 and has held it in 6 quarters since.
  • Evelyn Partners Asset Management's Foghorn Therapeutics position peaked at $38.3K in Q4 2025.
  • 105 funds tracked by Wall St. Rank held Foghorn Therapeutics as of Q1 2026.

Based on Evelyn Partners Asset Management's 13F filing for Q1 2026, filed 15 May 2026.